OVERVIEW

52nd Annual Gastroenterology Update – Controversies, Innovations, Research is organized by Cleveland Clinic Foundation and would be held on Nov 05, 2016 at Corporate College East, Warrensville Heights, Ohio, United States of America.

Target Audience :
This course is designed for practicing physicians, nurses, physician assistants, and nurse practitioners in gastroenterology, internal medicine, family practice, gastrointestinal surgery as well as Fellows in the field.

Overview of Course :
Advances in diagnosis and treatment of gastrointestinal (GI) disorders challenge GI practitioners to remain up-to-date on the most current data. This course addresses recent developments in the fields of inflammatory bowel disease and hepatology, and offers a comprehensive review of all areas of gastroenterology.

Objectives :
After this course participants will be able to:
• Discuss innovative endoscopic therapies for achalasia, locally invasive colorectal cancer, pancreatic pseudocysts, and strictures in Crohn’s disease patients.
• Describe how Cleveland Clinic physicians approach and resolve controversies in the management of GERD, IBS, chromoendoscopy in IBD, TIPS timing, liver transplantation timing, Barrett’s esophagus, and biosimilar use in IBD.
• Review the latest recommendations for management of patients with acute and chronic pancreatitis Critically review ongoing research projects from the Department of Gastroenterology at the Cleveland Clinic.

KEY DATES

Event Start Date
05 Nov, 2016
Event Start Date
Event End Date
05 Nov, 2016
Event End Date

SPECIALITIES

Gastroenterology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationCorporate College East
4400 Richmond Road

RELATED CONFERENCES & LIVE WEBINARS

By AdventHealth Nicholson Center

Aug 15, 2026 | Orlando, Florida, USA

Gastroenterology
6 MOC
...
More actions
Featured Conference
By Orlando Health Digestive Health...

Aug 20 - 22, 2026 | Orlando, Florida, USA

Gastroenterology
5 MOC
...
More actions
US$550

Oct 26 - 27, 2026 | Paris, ...

Gastroenterology
More actions
FR€350